James E. Fickenscher, Chief Financial Officer at AUXILIUM PHARMACEUTICALS INC (AUXL), sold 3,942 shares at $29.04 ($114K) on 2009-01-14, disclosed to the SEC on 2009-01-16.
Scheduled sale ($114k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |